The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cell Reprogramming Market Research Report 2025
Synopsis
Cell reprogramming is the process of reverting mature, specialised cells into induced pluripotent stem cells. Reprogramming also refers to the erasure and re-establishment of epigenetic marks during mammalian germ cell development.
The global Cell Reprogramming market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Cell Reprogramming is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cell Reprogramming is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Cell Reprogramming in Research & Academic Institutes is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Cell Reprogramming include Allele Biotechnology, ALSTEM, Applied Biological Materials, Axol Bioscience, Creative Bioarray, DefiniGEN, Fujifilm Cellular Dynamics, Lonza and Mogrify, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cell Reprogramming, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell Reprogramming.
Report Scope
The Cell Reprogramming market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cell Reprogramming market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell Reprogramming companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allele Biotechnology
ALSTEM
Applied Biological Materials
Axol Bioscience
Creative Bioarray
DefiniGEN
Fujifilm Cellular Dynamics
Lonza
Mogrify
REPROCELL
Stemnovate
Thermo Fisher Scientific
Segment by Type
Sendai virus-based Reprogramming
mRNA Reprogramming
Episomal Reprogramming
Others
Segment by Application
Research & Academic Institutes
Biotechnology & Pharmaceutical Companies
Hospitals & Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell Reprogramming companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Cell reprogramming is the process of reverting mature, specialised cells into induced pluripotent stem cells. Reprogramming also refers to the erasure and re-establishment of epigenetic marks during mammalian germ cell development.
The global Cell Reprogramming market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Cell Reprogramming is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cell Reprogramming is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Cell Reprogramming in Research & Academic Institutes is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Cell Reprogramming include Allele Biotechnology, ALSTEM, Applied Biological Materials, Axol Bioscience, Creative Bioarray, DefiniGEN, Fujifilm Cellular Dynamics, Lonza and Mogrify, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cell Reprogramming, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell Reprogramming.
Report Scope
The Cell Reprogramming market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cell Reprogramming market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell Reprogramming companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allele Biotechnology
ALSTEM
Applied Biological Materials
Axol Bioscience
Creative Bioarray
DefiniGEN
Fujifilm Cellular Dynamics
Lonza
Mogrify
REPROCELL
Stemnovate
Thermo Fisher Scientific
Segment by Type
Sendai virus-based Reprogramming
mRNA Reprogramming
Episomal Reprogramming
Others
Segment by Application
Research & Academic Institutes
Biotechnology & Pharmaceutical Companies
Hospitals & Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell Reprogramming companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Reprogramming Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Sendai virus-based Reprogramming
1.2.3 mRNA Reprogramming
1.2.4 Episomal Reprogramming
1.2.5 Others
1.3 Market by Application
1.3.1 Global Cell Reprogramming Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Research & Academic Institutes
1.3.3 Biotechnology & Pharmaceutical Companies
1.3.4 Hospitals & Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell Reprogramming Market Perspective (2019-2030)
2.2 Cell Reprogramming Growth Trends by Region
2.2.1 Global Cell Reprogramming Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cell Reprogramming Historic Market Size by Region (2019-2024)
2.2.3 Cell Reprogramming Forecasted Market Size by Region (2025-2030)
2.3 Cell Reprogramming Market Dynamics
2.3.1 Cell Reprogramming Industry Trends
2.3.2 Cell Reprogramming Market Drivers
2.3.3 Cell Reprogramming Market Challenges
2.3.4 Cell Reprogramming Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell Reprogramming Players by Revenue
3.1.1 Global Top Cell Reprogramming Players by Revenue (2019-2024)
3.1.2 Global Cell Reprogramming Revenue Market Share by Players (2019-2024)
3.2 Global Cell Reprogramming Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell Reprogramming Revenue
3.4 Global Cell Reprogramming Market Concentration Ratio
3.4.1 Global Cell Reprogramming Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Reprogramming Revenue in 2023
3.5 Cell Reprogramming Key Players Head office and Area Served
3.6 Key Players Cell Reprogramming Product Solution and Service
3.7 Date of Enter into Cell Reprogramming Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Reprogramming Breakdown Data by Type
4.1 Global Cell Reprogramming Historic Market Size by Type (2019-2024)
4.2 Global Cell Reprogramming Forecasted Market Size by Type (2025-2030)
5 Cell Reprogramming Breakdown Data by Application
5.1 Global Cell Reprogramming Historic Market Size by Application (2019-2024)
5.2 Global Cell Reprogramming Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cell Reprogramming Market Size (2019-2030)
6.2 North America Cell Reprogramming Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cell Reprogramming Market Size by Country (2019-2024)
6.4 North America Cell Reprogramming Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell Reprogramming Market Size (2019-2030)
7.2 Europe Cell Reprogramming Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cell Reprogramming Market Size by Country (2019-2024)
7.4 Europe Cell Reprogramming Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell Reprogramming Market Size (2019-2030)
8.2 Asia-Pacific Cell Reprogramming Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cell Reprogramming Market Size by Region (2019-2024)
8.4 Asia-Pacific Cell Reprogramming Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell Reprogramming Market Size (2019-2030)
9.2 Latin America Cell Reprogramming Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cell Reprogramming Market Size by Country (2019-2024)
9.4 Latin America Cell Reprogramming Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell Reprogramming Market Size (2019-2030)
10.2 Middle East & Africa Cell Reprogramming Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cell Reprogramming Market Size by Country (2019-2024)
10.4 Middle East & Africa Cell Reprogramming Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Allele Biotechnology
11.1.1 Allele Biotechnology Company Detail
11.1.2 Allele Biotechnology Business Overview
11.1.3 Allele Biotechnology Cell Reprogramming Introduction
11.1.4 Allele Biotechnology Revenue in Cell Reprogramming Business (2019-2024)
11.1.5 Allele Biotechnology Recent Development
11.2 ALSTEM
11.2.1 ALSTEM Company Detail
11.2.2 ALSTEM Business Overview
11.2.3 ALSTEM Cell Reprogramming Introduction
11.2.4 ALSTEM Revenue in Cell Reprogramming Business (2019-2024)
11.2.5 ALSTEM Recent Development
11.3 Applied Biological Materials
11.3.1 Applied Biological Materials Company Detail
11.3.2 Applied Biological Materials Business Overview
11.3.3 Applied Biological Materials Cell Reprogramming Introduction
11.3.4 Applied Biological Materials Revenue in Cell Reprogramming Business (2019-2024)
11.3.5 Applied Biological Materials Recent Development
11.4 Axol Bioscience
11.4.1 Axol Bioscience Company Detail
11.4.2 Axol Bioscience Business Overview
11.4.3 Axol Bioscience Cell Reprogramming Introduction
11.4.4 Axol Bioscience Revenue in Cell Reprogramming Business (2019-2024)
11.4.5 Axol Bioscience Recent Development
11.5 Creative Bioarray
11.5.1 Creative Bioarray Company Detail
11.5.2 Creative Bioarray Business Overview
11.5.3 Creative Bioarray Cell Reprogramming Introduction
11.5.4 Creative Bioarray Revenue in Cell Reprogramming Business (2019-2024)
11.5.5 Creative Bioarray Recent Development
11.6 DefiniGEN
11.6.1 DefiniGEN Company Detail
11.6.2 DefiniGEN Business Overview
11.6.3 DefiniGEN Cell Reprogramming Introduction
11.6.4 DefiniGEN Revenue in Cell Reprogramming Business (2019-2024)
11.6.5 DefiniGEN Recent Development
11.7 Fujifilm Cellular Dynamics
11.7.1 Fujifilm Cellular Dynamics Company Detail
11.7.2 Fujifilm Cellular Dynamics Business Overview
11.7.3 Fujifilm Cellular Dynamics Cell Reprogramming Introduction
11.7.4 Fujifilm Cellular Dynamics Revenue in Cell Reprogramming Business (2019-2024)
11.7.5 Fujifilm Cellular Dynamics Recent Development
11.8 Lonza
11.8.1 Lonza Company Detail
11.8.2 Lonza Business Overview
11.8.3 Lonza Cell Reprogramming Introduction
11.8.4 Lonza Revenue in Cell Reprogramming Business (2019-2024)
11.8.5 Lonza Recent Development
11.9 Mogrify
11.9.1 Mogrify Company Detail
11.9.2 Mogrify Business Overview
11.9.3 Mogrify Cell Reprogramming Introduction
11.9.4 Mogrify Revenue in Cell Reprogramming Business (2019-2024)
11.9.5 Mogrify Recent Development
11.10 REPROCELL
11.10.1 REPROCELL Company Detail
11.10.2 REPROCELL Business Overview
11.10.3 REPROCELL Cell Reprogramming Introduction
11.10.4 REPROCELL Revenue in Cell Reprogramming Business (2019-2024)
11.10.5 REPROCELL Recent Development
11.11 Stemnovate
11.11.1 Stemnovate Company Detail
11.11.2 Stemnovate Business Overview
11.11.3 Stemnovate Cell Reprogramming Introduction
11.11.4 Stemnovate Revenue in Cell Reprogramming Business (2019-2024)
11.11.5 Stemnovate Recent Development
11.12 Thermo Fisher Scientific
11.12.1 Thermo Fisher Scientific Company Detail
11.12.2 Thermo Fisher Scientific Business Overview
11.12.3 Thermo Fisher Scientific Cell Reprogramming Introduction
11.12.4 Thermo Fisher Scientific Revenue in Cell Reprogramming Business (2019-2024)
11.12.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Cell Reprogramming Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Sendai virus-based Reprogramming
Table 3. Key Players of mRNA Reprogramming
Table 4. Key Players of Episomal Reprogramming
Table 5. Key Players of Others
Table 6. Global Cell Reprogramming Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Cell Reprogramming Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Cell Reprogramming Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Cell Reprogramming Market Share by Region (2019-2024)
Table 10. Global Cell Reprogramming Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Cell Reprogramming Market Share by Region (2025-2030)
Table 12. Cell Reprogramming Market Trends
Table 13. Cell Reprogramming Market Drivers
Table 14. Cell Reprogramming Market Challenges
Table 15. Cell Reprogramming Market Restraints
Table 16. Global Cell Reprogramming Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Cell Reprogramming Market Share by Players (2019-2024)
Table 18. Global Top Cell Reprogramming Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Reprogramming as of 2023)
Table 19. Ranking of Global Top Cell Reprogramming Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Cell Reprogramming Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Cell Reprogramming Product Solution and Service
Table 23. Date of Enter into Cell Reprogramming Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cell Reprogramming Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Cell Reprogramming Revenue Market Share by Type (2019-2024)
Table 27. Global Cell Reprogramming Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Cell Reprogramming Revenue Market Share by Type (2025-2030)
Table 29. Global Cell Reprogramming Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Cell Reprogramming Revenue Market Share by Application (2019-2024)
Table 31. Global Cell Reprogramming Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Cell Reprogramming Revenue Market Share by Application (2025-2030)
Table 33. North America Cell Reprogramming Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Cell Reprogramming Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Cell Reprogramming Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Cell Reprogramming Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Cell Reprogramming Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Cell Reprogramming Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Cell Reprogramming Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Cell Reprogramming Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Cell Reprogramming Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Cell Reprogramming Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Cell Reprogramming Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Cell Reprogramming Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Cell Reprogramming Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Cell Reprogramming Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Cell Reprogramming Market Size by Country (2025-2030) & (US$ Million)
Table 48. Allele Biotechnology Company Detail
Table 49. Allele Biotechnology Business Overview
Table 50. Allele Biotechnology Cell Reprogramming Product
Table 51. Allele Biotechnology Revenue in Cell Reprogramming Business (2019-2024) & (US$ Million)
Table 52. Allele Biotechnology Recent Development
Table 53. ALSTEM Company Detail
Table 54. ALSTEM Business Overview
Table 55. ALSTEM Cell Reprogramming Product
Table 56. ALSTEM Revenue in Cell Reprogramming Business (2019-2024) & (US$ Million)
Table 57. ALSTEM Recent Development
Table 58. Applied Biological Materials Company Detail
Table 59. Applied Biological Materials Business Overview
Table 60. Applied Biological Materials Cell Reprogramming Product
Table 61. Applied Biological Materials Revenue in Cell Reprogramming Business (2019-2024) & (US$ Million)
Table 62. Applied Biological Materials Recent Development
Table 63. Axol Bioscience Company Detail
Table 64. Axol Bioscience Business Overview
Table 65. Axol Bioscience Cell Reprogramming Product
Table 66. Axol Bioscience Revenue in Cell Reprogramming Business (2019-2024) & (US$ Million)
Table 67. Axol Bioscience Recent Development
Table 68. Creative Bioarray Company Detail
Table 69. Creative Bioarray Business Overview
Table 70. Creative Bioarray Cell Reprogramming Product
Table 71. Creative Bioarray Revenue in Cell Reprogramming Business (2019-2024) & (US$ Million)
Table 72. Creative Bioarray Recent Development
Table 73. DefiniGEN Company Detail
Table 74. DefiniGEN Business Overview
Table 75. DefiniGEN Cell Reprogramming Product
Table 76. DefiniGEN Revenue in Cell Reprogramming Business (2019-2024) & (US$ Million)
Table 77. DefiniGEN Recent Development
Table 78. Fujifilm Cellular Dynamics Company Detail
Table 79. Fujifilm Cellular Dynamics Business Overview
Table 80. Fujifilm Cellular Dynamics Cell Reprogramming Product
Table 81. Fujifilm Cellular Dynamics Revenue in Cell Reprogramming Business (2019-2024) & (US$ Million)
Table 82. Fujifilm Cellular Dynamics Recent Development
Table 83. Lonza Company Detail
Table 84. Lonza Business Overview
Table 85. Lonza Cell Reprogramming Product
Table 86. Lonza Revenue in Cell Reprogramming Business (2019-2024) & (US$ Million)
Table 87. Lonza Recent Development
Table 88. Mogrify Company Detail
Table 89. Mogrify Business Overview
Table 90. Mogrify Cell Reprogramming Product
Table 91. Mogrify Revenue in Cell Reprogramming Business (2019-2024) & (US$ Million)
Table 92. Mogrify Recent Development
Table 93. REPROCELL Company Detail
Table 94. REPROCELL Business Overview
Table 95. REPROCELL Cell Reprogramming Product
Table 96. REPROCELL Revenue in Cell Reprogramming Business (2019-2024) & (US$ Million)
Table 97. REPROCELL Recent Development
Table 98. Stemnovate Company Detail
Table 99. Stemnovate Business Overview
Table 100. Stemnovate Cell Reprogramming Product
Table 101. Stemnovate Revenue in Cell Reprogramming Business (2019-2024) & (US$ Million)
Table 102. Stemnovate Recent Development
Table 103. Thermo Fisher Scientific Company Detail
Table 104. Thermo Fisher Scientific Business Overview
Table 105. Thermo Fisher Scientific Cell Reprogramming Product
Table 106. Thermo Fisher Scientific Revenue in Cell Reprogramming Business (2019-2024) & (US$ Million)
Table 107. Thermo Fisher Scientific Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell Reprogramming Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Cell Reprogramming Market Share by Type: 2023 VS 2030
Figure 3. Sendai virus-based Reprogramming Features
Figure 4. mRNA Reprogramming Features
Figure 5. Episomal Reprogramming Features
Figure 6. Others Features
Figure 7. Global Cell Reprogramming Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Cell Reprogramming Market Share by Application: 2023 VS 2030
Figure 9. Research & Academic Institutes Case Studies
Figure 10. Biotechnology & Pharmaceutical Companies Case Studies
Figure 11. Hospitals & Clinics Case Studies
Figure 12. Cell Reprogramming Report Years Considered
Figure 13. Global Cell Reprogramming Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Cell Reprogramming Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Cell Reprogramming Market Share by Region: 2023 VS 2030
Figure 16. Global Cell Reprogramming Market Share by Players in 2023
Figure 17. Global Top Cell Reprogramming Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Reprogramming as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Cell Reprogramming Revenue in 2023
Figure 19. North America Cell Reprogramming Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Cell Reprogramming Market Share by Country (2019-2030)
Figure 21. United States Cell Reprogramming Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Cell Reprogramming Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Cell Reprogramming Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Cell Reprogramming Market Share by Country (2019-2030)
Figure 25. Germany Cell Reprogramming Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Cell Reprogramming Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Cell Reprogramming Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Cell Reprogramming Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Cell Reprogramming Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Cell Reprogramming Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Cell Reprogramming Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Cell Reprogramming Market Share by Region (2019-2030)
Figure 33. China Cell Reprogramming Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Cell Reprogramming Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Cell Reprogramming Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Cell Reprogramming Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Cell Reprogramming Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Cell Reprogramming Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Cell Reprogramming Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Cell Reprogramming Market Share by Country (2019-2030)
Figure 41. Mexico Cell Reprogramming Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Cell Reprogramming Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Cell Reprogramming Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Cell Reprogramming Market Share by Country (2019-2030)
Figure 45. Turkey Cell Reprogramming Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Cell Reprogramming Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Allele Biotechnology Revenue Growth Rate in Cell Reprogramming Business (2019-2024)
Figure 48. ALSTEM Revenue Growth Rate in Cell Reprogramming Business (2019-2024)
Figure 49. Applied Biological Materials Revenue Growth Rate in Cell Reprogramming Business (2019-2024)
Figure 50. Axol Bioscience Revenue Growth Rate in Cell Reprogramming Business (2019-2024)
Figure 51. Creative Bioarray Revenue Growth Rate in Cell Reprogramming Business (2019-2024)
Figure 52. DefiniGEN Revenue Growth Rate in Cell Reprogramming Business (2019-2024)
Figure 53. Fujifilm Cellular Dynamics Revenue Growth Rate in Cell Reprogramming Business (2019-2024)
Figure 54. Lonza Revenue Growth Rate in Cell Reprogramming Business (2019-2024)
Figure 55. Mogrify Revenue Growth Rate in Cell Reprogramming Business (2019-2024)
Figure 56. REPROCELL Revenue Growth Rate in Cell Reprogramming Business (2019-2024)
Figure 57. Stemnovate Revenue Growth Rate in Cell Reprogramming Business (2019-2024)
Figure 58. Thermo Fisher Scientific Revenue Growth Rate in Cell Reprogramming Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
